Literature DB >> 26077263

Primary prevention for type 1 diabetes mellitus?

Bart O Roep1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26077263     DOI： 10.1038/nrendo.2015.95

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN： 1759-5029            Impact factor:   43.330


× No keyword cloud information.
  10 in total

1.  Effects of high-dose oral insulin on immune responses in children at high risk for type 1 diabetes: the Pre-POINT randomized clinical trial.

Authors:  Ezio Bonifacio; Anette-G Ziegler; Georgeanna Klingensmith; Edith Schober; Polly J Bingley; Marietta Rottenkolber; Anke Theil; Anne Eugster; Ramona Puff; Claudia Peplow; Florian Buettner; Karin Lange; Jörg Hasford; Peter Achenbach
Journal:  JAMA       Date:  2015-04-21       Impact factor: 56.272

2.  Effects of oral insulin in relatives of patients with type 1 diabetes: The Diabetes Prevention Trial--Type 1.

Authors:  Jay S Skyler; Jeffrey P Krischer; Joseph Wolfsdorf; Catherine Cowie; Jerry P Palmer; Carla Greenbaum; David Cuthbertson; Lisa E Rafkin-Mervis; H Peter Chase; Ellen Leschek
Journal:  Diabetes Care       Date:  2005-05       Impact factor: 19.112

3.  Early infant feeding and risk of developing type 1 diabetes-associated autoantibodies.

Authors:  Anette-G Ziegler; Sandra Schmid; Doris Huber; Michael Hummel; Ezio Bonifacio
Journal:  JAMA       Date:  2003-10-01       Impact factor: 56.272

4.  Nasal insulin to prevent type 1 diabetes in children with HLA genotypes and autoantibodies conferring increased risk of disease: a double-blind, randomised controlled trial.

Authors:  Kirsti Näntö-Salonen; Antti Kupila; Satu Simell; Heli Siljander; Tiina Salonsaari; Anne Hekkala; Sari Korhonen; Risto Erkkola; Jukka I Sipilä; Lotta Haavisto; Marja Siltala; Juhani Tuominen; Jari Hakalax; Heikki Hyöty; Jorma Ilonen; Riitta Veijola; Tuula Simell; Mikael Knip; Olli Simell
Journal:  Lancet       Date:  2008-09-22       Impact factor: 79.321

5.  Naturally arising human CD4 T-cells that recognize islet autoantigens and secrete interleukin-10 regulate proinflammatory T-cell responses via linked suppression.

Authors:  Timothy I M Tree; Jennifer Lawson; Hannah Edwards; Ania Skowera; Sefina Arif; Bart O Roep; Mark Peakman
Journal:  Diabetes       Date:  2010-03-18       Impact factor: 9.461

6.  Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin.

Authors:  Z J Zhang; L Davidson; G Eisenbarth; H L Weiner
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-15       Impact factor: 11.205

7.  European Nicotinamide Diabetes Intervention Trial (ENDIT): a randomised controlled trial of intervention before the onset of type 1 diabetes.

Authors:  E A M Gale; P J Bingley; C L Emmett; T Collier
Journal:  Lancet       Date:  2004-03-20       Impact factor: 79.321

8.  Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children.

Authors:  Anette G Ziegler; Marian Rewers; Olli Simell; Tuula Simell; Johanna Lempainen; Andrea Steck; Christiane Winkler; Jorma Ilonen; Riitta Veijola; Mikael Knip; Ezio Bonifacio; George S Eisenbarth
Journal:  JAMA       Date:  2013-06-19       Impact factor: 56.272

9.  Genotype effects and epistasis in type 1 diabetes and HLA-DQ trans dimer associations with disease.

Authors:  B P C Koeleman; B A Lie; D E Undlien; F Dudbridge; E Thorsby; R R P de Vries; F Cucca; B O Roep; M J Giphart; J A Todd
Journal:  Genes Immun       Date:  2004-08       Impact factor: 2.676

Review 10.  Immune modulation in humans: implications for type 1 diabetes mellitus.

Authors:  Bart O Roep; Timothy I M Tree
Journal:  Nat Rev Endocrinol       Date:  2014-01-28       Impact factor: 43.330
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.